OrthoPediatrics (NASDAQ: KIDS) net income
OrthoPediatrics reported a net loss of $39.6m for fiscal 2025; in fiscal 2024 it reported a net loss of $37.8m. Earnings per share were −$1.69.
OrthoPediatrics's best year of the last 10 was fiscal 2022. It reported a loss in 9 of those 10 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$39.6m | — | −16.8% | −$1.69 |
| 2024 | −$37.8m | — | −18.5% | −$1.64 |
| 2023 | −$21.0m | −1,767.2% | −14.1% | −$0.92 |
| 2022 | $1.3m | — | 1.0% | $0.06 |
| 2021 | −$16.3m | — | −16.6% | −$0.84 |
| 2020 | −$32.9m | — | −46.3% | −$1.82 |
| 2019 | −$13.7m | — | −18.9% | −$0.94 |
| 2018 | −$12.0m | — | −20.9% | — |
| 2017 | −$8.9m | — | −19.6% | — |
| 2016 | −$6.6m | — | −17.6% | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
OrthoPediatrics net income compared with its sector
By net income for its latest fiscal year, OrthoPediatrics ranks 242nd of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of OrthoPediatrics, −16.8%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 240th | TriSalus Life Sciences | −$39.2m | −86.9% |
| 241st | Elicio Therapeutics | −$39.6m | — |
| 242nd | OrthoPediatrics | −$39.6m | −16.8% |
| 243rd | Palvella Therapeutics | −$41.7m | — |
| 244th | Trevi Therapeutics | −$42.8m | — |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of OrthoPediatrics
- How much did OrthoPediatrics earn in fiscal 2025?
- OrthoPediatrics reported a net loss of $39.6m for fiscal 2025. In fiscal 2024 it reported a net loss of $37.8m.
- What are the earnings per share of OrthoPediatrics?
- They were −$1.69 in fiscal 2025, compared with −$1.64 in fiscal 2024.
- What was the most profitable year for OrthoPediatrics?
- Of its last 10 fiscal years, fiscal 2022, with $1.3m.
- Where does OrthoPediatrics rank in its sector by net income?
- It ranks 242nd of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for OrthoPediatrics come from?
- From the annual report (Form 10-K) that OrthoPediatrics files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that OrthoPediatrics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on OrthoPediatrics: the OrthoPediatrics page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.